Designing, Developing, and Testing a Chatbot for Parents and Caregivers of Children and Young People With Rheumatological Conditions (the IMPACT Study): Protocol for a Co-Designed Proof-of-Concept Study.

caregivers chatbot paediatric rheumatology parents and caregivers parents/carers pediatric proof-of-concept quality of life rheumatology

Journal

JMIR research protocols
ISSN: 1929-0748
Titre abrégé: JMIR Res Protoc
Pays: Canada
ID NLM: 101599504

Informations de publication

Date de publication:
03 04 2024
Historique:
received: 08 02 2024
accepted: 04 03 2024
revised: 28 02 2024
medline: 3 4 2024
pubmed: 3 4 2024
entrez: 3 4 2024
Statut: epublish

Résumé

Pediatric rheumatology is a term that encompasses over 80 conditions affecting different organs and systems. Children and young people with rheumatological chronic conditions are known to have high levels of mental health problems and therefore are at risk of poor health outcomes. Clinical psychologists can help children and young people manage the daily difficulties of living with one of these conditions; however, there are insufficient pediatric psychologists in the United Kingdom. We urgently need to consider other ways of providing early, essential support to improve their current well-being. One way of doing this is to empower parents and caregivers to have more of the answers that their children and young people need to support them further between their hospital appointments. The objective of this co-designed proof-of-concept study is to design, develop, and test a chatbot intervention to support parents and caregivers of children and young people with rheumatological conditions. This study will explore the needs and views of children and young people with rheumatological conditions, their siblings, parents, and caregivers, as well as health care professionals working in pediatric rheumatology. We will ask approximately 100 participants in focus groups where they think the gaps are in current clinical care and what ideas they have for improving upon them. Creative experience-based co-design workshops will then decide upon top priorities to develop further while informing the appearance, functionality, and practical delivery of a chatbot intervention. Upon completion of a minimum viable product, approximately 100 parents and caregivers will user-test the chatbot intervention in an iterative sprint methodology to determine its worth as a mechanism for support for parents. A total of 73 children, young people, parents, caregivers, and health care professionals have so far been enrolled in the study, which began in November 2023. The anticipated completion date of the study is April 2026. The data analysis is expected to be completed in January 2026, with the results being published in April 2026. This study will provide evidence on the accessibility, acceptability, and usability of a chatbot intervention for parents and caregivers of children and young people with rheumatological conditions. If proven useful, it could lead to a future efficacy trial of one of the first chatbot interventions to provide targeted and user-suggested support for parents and caregivers of children with chronic health conditions in health care services. This study is unique in that it will detail the needs and wants of children, young people, siblings, parents, and caregivers to improve the current support given to families living with pediatric rheumatological conditions. It will be conducted across the whole of the United Kingdom for all pediatric rheumatological conditions at all stages of the disease trajectory. DERR1-10.2196/57238.

Sections du résumé

BACKGROUND
Pediatric rheumatology is a term that encompasses over 80 conditions affecting different organs and systems. Children and young people with rheumatological chronic conditions are known to have high levels of mental health problems and therefore are at risk of poor health outcomes. Clinical psychologists can help children and young people manage the daily difficulties of living with one of these conditions; however, there are insufficient pediatric psychologists in the United Kingdom. We urgently need to consider other ways of providing early, essential support to improve their current well-being. One way of doing this is to empower parents and caregivers to have more of the answers that their children and young people need to support them further between their hospital appointments.
OBJECTIVE
The objective of this co-designed proof-of-concept study is to design, develop, and test a chatbot intervention to support parents and caregivers of children and young people with rheumatological conditions.
METHODS
This study will explore the needs and views of children and young people with rheumatological conditions, their siblings, parents, and caregivers, as well as health care professionals working in pediatric rheumatology. We will ask approximately 100 participants in focus groups where they think the gaps are in current clinical care and what ideas they have for improving upon them. Creative experience-based co-design workshops will then decide upon top priorities to develop further while informing the appearance, functionality, and practical delivery of a chatbot intervention. Upon completion of a minimum viable product, approximately 100 parents and caregivers will user-test the chatbot intervention in an iterative sprint methodology to determine its worth as a mechanism for support for parents.
RESULTS
A total of 73 children, young people, parents, caregivers, and health care professionals have so far been enrolled in the study, which began in November 2023. The anticipated completion date of the study is April 2026. The data analysis is expected to be completed in January 2026, with the results being published in April 2026.
CONCLUSIONS
This study will provide evidence on the accessibility, acceptability, and usability of a chatbot intervention for parents and caregivers of children and young people with rheumatological conditions. If proven useful, it could lead to a future efficacy trial of one of the first chatbot interventions to provide targeted and user-suggested support for parents and caregivers of children with chronic health conditions in health care services. This study is unique in that it will detail the needs and wants of children, young people, siblings, parents, and caregivers to improve the current support given to families living with pediatric rheumatological conditions. It will be conducted across the whole of the United Kingdom for all pediatric rheumatological conditions at all stages of the disease trajectory.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID)
DERR1-10.2196/57238.

Identifiants

pubmed: 38568725
pii: v13i1e57238
doi: 10.2196/57238
pmc: PMC11024752
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e57238

Investigateurs

Eire Byrne (E)
Natalia Kasaru (N)
Morgan Pawlett (M)
Cameron Papantoniou (C)
Emily Earle (E)
Nathanael Bourns (N)
Rachel Pulfree-Blythe (R)
Eunice Kasaru (E)
Emma Piepenstock (E)
Gemma Molyneux (G)
Heather Rostron (H)

Informations de copyright

©Polly Livermore, Klaudia Kupiec, Lucy R Wedderburn, Andrea Knight, Ameenat L Solebo, Roz Shafran, Glenn Robert, N J Sebire, Faith Gibson, IMPACT Steering Group. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 03.04.2024.

Références

Rheumatology (Oxford). 2010 Jul;49(7):1406-8
pubmed: 20173199
Front Digit Health. 2021 Oct 06;3:735053
pubmed: 34713203
BMJ. 2015 Feb 10;350:g7714
pubmed: 25670179
Digit Health. 2019 Aug 21;5:2055207619871808
pubmed: 31467682
Patient Educ Couns. 2022 Jun;105(6):1488-1494
pubmed: 34649750
Pediatr Rheumatol Online J. 2021 Feb 23;19(1):19
pubmed: 33622346
Pediatr Rheumatol Online J. 2023 Oct 6;21(1):111
pubmed: 37798784
Arthritis Care Res (Hoboken). 2019 May;71(5):591-601
pubmed: 29953741
Pediatr Nurs. 2006 Jan-Feb;32(1):51-9
pubmed: 16572539
JMIR Ment Health. 2017 Jun 06;4(2):e19
pubmed: 28588005
Pediatr Rev. 2006 Apr;27(4):e24-32
pubmed: 16581950
BMJ. 2021 Sep 30;374:n2061
pubmed: 34593508
Vis Comput Ind Biomed Art. 2023 May 18;6(1):9
pubmed: 37198498
Rheum Dis Clin North Am. 2022 Feb;48(1):67-90
pubmed: 34798960
Health Informatics J. 2023 Jan-Mar;29(1):14604582221146719
pubmed: 36693014
Lancet Child Adolesc Health. 2019 Jan;3(1):8-9
pubmed: 30473439
Ann Rheum Dis. 2016 Jan;75(1):190-5
pubmed: 25362042
J Head Trauma Rehabil. 2022 May-Jun 01;37(3):144-151
pubmed: 35293365
Rheumatol Adv Pract. 2021 Sep 10;5(3):rkab062
pubmed: 34671713
Pediatr Rheumatol Online J. 2017 Dec 28;15(1):85
pubmed: 29282086

Auteurs

Polly Livermore (P)

Rheumatology Department, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom.
NIHR Biomedical Research Centre at Great Ormond Street Hospital for Children, London, United Kingdom.
University College London Great Ormond Street Institute of Child Health, London, United Kingdom.
Centre for Adolescent Rheumatology Versus Arthritis at UCL, UCLH and GOSH, London, United Kingdom.

Klaudia Kupiec (K)

Rheumatology Department, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom.

Lucy R Wedderburn (LR)

NIHR Biomedical Research Centre at Great Ormond Street Hospital for Children, London, United Kingdom.
University College London Great Ormond Street Institute of Child Health, London, United Kingdom.
Centre for Adolescent Rheumatology Versus Arthritis at UCL, UCLH and GOSH, London, United Kingdom.

Andrea Knight (A)

Division of Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada.
Neurosciences and Mental Health Program, SickKids Research Institute, Toronto, ON, Canada.
Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.

Ameenat L Solebo (AL)

University College London Great Ormond Street Institute of Child Health, London, United Kingdom.
Opthamology Department, Great Ormond Street Children's Hospital NHS Foundation Trust, London, United Kingdom.

Roz Shafran (R)

University College London Great Ormond Street Institute of Child Health, London, United Kingdom.

Glenn Robert (G)

Kings College London, London, United Kingdom.

N J Sebire (NJ)

University College London Great Ormond Street Institute of Child Health, London, United Kingdom.

Faith Gibson (F)

School of Health Sciences, University of Surrey, Surrey, United Kingdom.
Director of Research - Nursing and Allied Health, Great Ormond Street Children's Hospital, London, United Kingdom.
See Acknowledgments, .

Classifications MeSH